Navigation Links
Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
Date:12/4/2008

Side effects similar to those seen with standard dose of daunorubicin, study shows

THURSDAY, Dec. 4 (HealthDay News) -- A high dose of the chemotherapy drug daunorubicin prolonged survival for patients with previously untreated acute myeloid leukemia (AML), preliminary results of a study sponsored by the U.S. National Cancer Institute (NCI) show.

AML is a cancer of the blood and bone marrow. This study included 633 patients, aged 16 to 60, who were randomly assigned to receive either high-dose or standard-dose daunorubicin.

Both doses were given in combination with another chemotherapy drug called ara-C (cytarabine). The patients in the high-dose group received 90 milligrams of daunorubicin per square meter of body surface area (90 mg/m2) on each of the first three days of treatment. The standard dose is 45 mg/m2.

Patients in the high-dose group had a median overall survival of 23.7 months, compared to 15.1 months for those in the standard-dose group. Both groups had similar frequencies of serious treatment-related toxicity, according to the study, conducted by a network of researchers led by the Eastern Cooperative Oncology Group (ECOG).

"The findings of this large clinical trial are important, because they will likely change practice and improve the outcome for many patients with AML," Dr. Martin Tallman, chairman of the ECOG leukemia committee and a professor of medicine at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, said in an NCI news release.

Daunorubicin is already FDA-approved for treatment of AML, which means that patients with the disease may gain immediate benefit from the findings.

More than 13,000 people in the United States will be diagnosed with AML in 2008. Most cases occur in adults, and about half occur in those younger than 60. Only about one-third of AML patients survive the disease, and the odds of survival decrease with age.

More information

The American Cancer Society has more about acute myeloid leukemia.



-- Robert Preidt



SOURCE: U.S. National Cancer Institute, news release, Nov. 17, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Higher rates of mental illness among the homeless in Western countries
2. Risk of death may be higher with drug commonly used during cardiac surgery
3. Potassium loss from blood pressure drugs may explain higher risk of adult diabetes
4. Avandias Heart Risk Higher Than Others in Its Class
5. TargetScan Evaluation is Shown to Deliver Potentially Higher Cancer Detection Rate and More Accurate Assessment of Grade
6. Physicians Anticipate Higher Prescribing Based on JUPITER Study
7. Non-AIDS Cancer Risk Higher for Those With HIV
8. Death Rates Higher for Minority Children Awaiting Heart Transplant
9. Mesa Labs Reports Higher Quarterly Sales and Earnings
10. Rural women are at higher risk of blood pressure disorders during pregnancy
11. Liver transplant recipients have higher cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Leading pediatric oncology ... in Washington, D.C., for the 49th Congress of the International Society of Paediatric ... President of the Center for Cancer and Blood Disorders at Children’s National, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United ... year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and ... havens have extremely low property-tax rates, which contributes to the relatively lower cost ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward ... and other leading institutions in announcing the launch of the Leadership Circle ... way animals are raised for food. , Founding members of the Leadership Circle ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017   Divoti USA will engrave ... the standard of the latest FDA requirements, which stipulates new criteria ... Anyone in need of Medical ID jewelry such as Medical ID ... are engraved in terms of the new FDA requirements . ... Divoti offers this dark mark ...
(Date:10/11/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers were ... innovative way to use nonlinear optical imaging to confirm ... drugs. A ... show how researchers from BioPharmX and the Wellman Center ... a suite of imaging techniques in what is called ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
Breaking Medicine Technology: